Orahealth Laboratories LLC is categorized under Lozenges, Candy (Non-Medicated) in Irvine, CA and active since 1999.
Orahealth Laboratories LLC was established in 1999, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Lozenges, Candy (Non-Medicated) business, which does work in the BOTH market, and is classified as a Lozenges, Candy (Non-Medicated), under code number 311340 by the NAICS.
If you are seeking more information, feel free to contact Brian Taus at the company’s single location by writing to 2222 Michelson Drive 444, Irvine, California CA 92612 or by phoning (949) 378-6067. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Orahealth Laboratories LLC |
| Contact Person: | Brian Taus |
| Address: | 2222 Michelson Drive 444, Irvine, California 92612 |
| Phone Number: | (949) 378-6067 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Lozenges, Candy (Non-Medicated) |
| SIC Code: | 2064 |
| NAICS Code: | 311340 |
| Share This Business: |
Orahealth Laboratories LLC was started in 1999 to provide professional Lozenges, Candy (Non-Medicated) under the SIC code 2064 and NAICS code 311340. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Brian Taus for inquiries that concern Orahealth Laboratories LLC by calling the company number (949) 378-6067, as your correspondence is most welcome. Additionally, the physical location of the single location of Orahealth Laboratories LLC can be found at the coordinates 33.676818,-117.855735 as well as the street address 2222 Michelson Drive 444 in Irvine, California 92612.
For its online presence, you may visit Orahealth Laboratories LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.